Clinical trials
Obesity clinical trials
Excess body weight that increases the risk of many other health conditions. We’re tracking 1,500 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07209995Enrolling by invitation
Ultrasound-guided arm block for obese patients
This trial compares two types of ultrasound-guided nerve blocks for obese patients having surgery on or below the elbow. The goal is to find which approach works best for this group.
ZagazigAges 21–45 - NCT06561529Recruiting
Stomach bypass stent for liver scarring in obese patients
This study tests a stomach bypass stent to treat liver scarring caused by fatty liver disease in people with obesity. If you have obesity and a confirmed liver condition called NASH with moderate scarring, this stent might help you achieve weight loss and improve your liver health.
Riga, RigaAges 18–65 - NCT06973980Recruiting
High-intensity exercise for weight loss in young adults
This study tests whether high-intensity interval training (short bursts of intense exercise) can improve health in sedentary young adults with obesity. If you are between 20 and 35, have a BMI of 30 to 35, and do little to no exercise, this trial may be a good fit.
FamagustaAges 20–35 - NCT06818500Recruiting
Body composition and blood vessel health in women with a healthy weight
This study looks at how body composition (muscle and fat) affects blood vessel health in women who have a healthy body weight. The goal is to learn more about blood vessel function in this group.
Muncie, IndianaAges 18–50 - NCT07423247RecruitingPhase 4
Tirzepatide for weight loss in kidney transplant patients
This trial tests if tirzepatide can help people who have had a kidney transplant and are still overweight lose weight. It may be an option if you have had your transplant at least a year ago, your kidney function is stable, and your body mass index is 27 or higher.
TehranAges 18 years+ - NCT07355738RecruitingPhase 1
Bioequivalence study of GZR18 injection
This study tests whether a change in the manufacturing process for GZR18 (an experimental injectable drug) affects how it works in the body. It may help determine if the new version is as safe and effective as the original.
Suzhou, SuzhouAges 18–50 - NCT06644911Recruiting
Obesity and Doppler ultrasound in full-term pregnancy
This study uses a special ultrasound (Doppler) to check blood flow in the umbilical cord of full-term pregnant women who are either obese or normal weight. It aims to see if obesity affects the baby's well-being before birth.
AsyutAges 20–35 - NCT05895968Recruiting
Barbed Suture for Obese Patients Having Neck Surgery
This trial tests a special type of stitch (called barb suture) used during back-of-neck surgery. It is for people who are obese and need surgery for cervical spinal problems, to see if it helps recovery.
Xi'an, Shannxi ProvinceAges 28–85 - NCT07096011Recruiting
Studying obesity risks in young infants
This study looks at very young babies to understand early signs of obesity risk. If your baby is under 4 months old and mainly drinks breastmilk, they may help researchers learn more about how body growth and feeding relate to health later in life.
Baton Rouge, LouisianaAges 2 weeks–4 months - NCT07213271Recruiting
Exercise study for obese breast cancer survivors
This study tests whether a physical exercise program can improve metabolism, gut health, fitness, and quality of life in obese women who have completed breast cancer treatment at least one year ago.
BratislavaAges 25–70 - NCT07528963Enrolling by invitation
Enhanced Cancer Survivorship Care in Rural Kansas Clinics
This study tests a new model of cancer care designed for rural areas, focusing on helping breast, prostate, lung, and colorectal cancer survivors manage their health after treatment. The study works through primary care clinics to make survivorship care more accessible and effective.
Kansas City, KansasAges 18–75 - NCT07313293Recruiting
Foot reflexology for nausea after weight-loss surgery
This trial tests if foot reflexology can help reduce nausea after sleeve gastrectomy (a type of weight-loss surgery). You may join if you are scheduled for this surgery and do not have foot problems or take strong pain medications.
La Roche-sur-YonAges 18 years+ - NCT07151105Recruiting
Vitamin C for gut health in adults with obesity
This trial tests whether taking vitamin C supplements helps improve gut barrier function in adults with obesity. You'll follow a low-fruit-and-vegetable diet for two, two-week periods.
Columbus, OhioAges 18–50 - NCT05943626Recruiting
Sleep timing changes to improve heart and blood sugar health
This study tests whether changing your sleep habits can improve heart-related health and blood sugar control. You may be asked to follow a sleep schedule and other routines, and outcomes will be measured over time.
Salt Lake City, UtahAges 18–45 - NCT05477277Recruiting
MRI testing during liver transplant evaluation
This study looks at whether having an MRI scan during liver transplant planning helps predict who may have worse outcomes or higher risk of death. It focuses on adults with severe liver disease who are already being considered for a transplant.
Phoenix, ArizonaAges 18 years+ - NCT07743983RecruitingPhase 3
Study of BGM0504 in Early Type 2 Diabetes with Obesity
This trial tests an investigational drug, BGM0504, for people recently diagnosed with type 2 diabetes who also have obesity. It aims to see if the drug can help control blood sugar and support weight loss.
Nanjing, JiangsuAges 18–75 - NCT07225686RecruitingPhase 3
Maridebart Cafraglutide for sleep apnea in adults on CPAP
This study is testing whether a new medicine, called Maridebart Cafraglutide, can help people with obstructive sleep apnea who are already using a CPAP machine. The medicine may help with weight loss and potentially improve sleep apnea. Participants will either receive the medicine or a placebo (an inactive substance), and the study lasts for several months.
Northridge, CaliforniaAges 18–99 - NCT07743567Recruiting
Weight and pregnancy outcomes after GLP-1 use
This study looks at how a type of weight-loss medication called GLP-1 affects pregnancy and baby outcomes. It aims to learn if this medication is safe to use early in pregnancy.
Kansas City, KansasAges 18–45 - NCT07684235RecruitingPhase 3
Long-term study of a weight-loss drug for trial graduates
This study tests a drug called Maridebart Cafraglutide for long-term weight management in people who completed a previous related trial. It looks at how well the drug works and its safety over time.
Daphne, AlabamaAges 18–99 - NCT07742917Recruiting
Personalized lifestyle program for weight management
This program tests a personalized lifestyle plan designed to help you manage your weight and improve your health. It uses your genetic information and other personal data to tailor the support you receive.
Abu DhabiAges 25–50 - NCT07740291Recruiting
Tirzepatide and lifestyle study for weight loss
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
Lubbock, TexasAges 18 years+ - NCT07619989Recruiting
Ear nerve stimulation for weight loss after tirzepatide
This trial tests if a gentle electrical stimulation to the ear can help people who haven't lost much weight with tirzepatide (a diabetes/weight drug). It's for people who are still overweight after 12 weeks of treatment.
Nanjing, JiangsuAges 18–50 - NCT06619041Recruiting
HealthyTogether: Weight Management with a Partner
This study tests a weight management program where you and a partner (like a spouse or friend) work together virtually. It aims to help you lose weight and improve health habits alongside someone you trust.
Aurora, ColoradoAges 18 years+ - NCT06374875RecruitingPhase 4
Does metabolic surgery reduce liver scarring?
This study tests if weight loss surgery can improve liver fibrosis (scarring) in people with obesity and advanced liver disease. It may help those considering surgery to know if their liver health can get better.
Phoenix, ArizonaAges 18–75
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obesity?
- Yes. Clin2 currently lists 1,500 recruiting obesity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obesity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obesity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.